SES Solar Inc.
SES Solar Inc.
Your view on SESI
Overview
What the company does, where it operates, and who runs it.
About SES Solar Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Philippe Crisafulli
- Headquarters
- Chemin du Champ-des-Filles 36, Plan-les-Ouates, CH
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Philippe Crisafulli
- Headquarters
- Chemin du Champ-des-Filles 36, Plan-les-Ouates, CH
SES Solar Inc. develops and delivers products in the field of photovoltaic energy in Switzerland.
The company offers a range of photovoltaic products, such as solar tiles that comprise standard panels primarily for urban or rural areas, and flat or sloped roofs; and custom/architecturally integrated panels made of glass/glass tedlar, which are used for glazing, light admitting apertures in industrial and residential buildings, as well as for veranda roofs.
It also handles project management services from design to completion, as well as provides monitoring (supervision), maintenance, and operation services. The company was founded in 2001 and is based in Plan-les-Ouates, Switzerland. As of November 23, 2010, SES Solar Inc. operates as a subsidiary of Flannel Management Sàrl.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for SES Solar Inc., and the rating behind it. SESI last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for SES Solar Inc.. Starting points for SES Solar Inc.: beta -14.94 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for SES Solar Inc.. SES Solar Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for SES Solar Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for SES Solar Inc.. SES Solar Inc. has reported as a listed company since 2006. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
SES Solar Inc. valued side by side against its closest peers. SES Solar Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold SES Solar Inc., and how their positions are changing. At a $7,308 market value, institutional positions materially move SES Solar Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by SES Solar Inc. executives and directors. Shares of SES Solar Inc. have traded between $0.0001 and $0.03 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming SES Solar Inc.. SES Solar Inc. is a $7,308 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming SES Solar Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for SES Solar Inc.. Coverage tracks SES Solar Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.